Merck

+$2.34 (+3.03%) Today
+$0.09 (+0.11%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Merck and other ETFs, options, and stocks.

About MRK

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.

CEO
Robert M. Davis
Employees
74,000
Headquarters
Kenilworth, New Jersey
Founded
1891

MRK Key Statistics

Market Cap
201.22B
Price-Earnings Ratio
35.22
Dividend Yield
3.37
Average Volume
14.60M
High Today
$79.52
Low Today
$78.11
Open Price
$78.73
Volume
15.58M
52 Week High
$85.60
52 Week Low
$70.89

MRK News

Barron's15h

Atea Pharma Stumbles in Race for a Covid Pill. The Stock Fell 76%.

Reuters The news puts Atea and Roche far behind U.S.-based Merck & Co Inc in the race to a pill to treat COVID-19. Merck applied for U.S. emergency use authori
Reuters15h

Atea plunges after COVID-19 treatment fails to help patients in study

The word "COVID-19" is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration Oct 19 (Reuters) -
Fox BusinessOct 17

Merck COVID-19 pill sparks calls for access for lower income countries

The plan to roll out Merck & Co's promising antiviral pill to treat COVID-19 risks repeating the inequities of vaccine distribution, potentially leaving the nat

MRK Earnings

$0.00
$0.58
$1.16
$1.74
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Available Oct 28, Pre-Market

More MRK News

MarketWatchOct 15

Merck Gets CHMP Positive Opinion for Vaxneuvance Vaccine

By Colin Kellaher Merck & Co. on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of its Vaxneuv
MarketWatchOct 15

Why a pill you take at home could change the direction of the pandemic

Merck and Ridgeback Biotherapeutics’ promising oral antiviral could shift the direction of the pandemic by making it easier for people with COVID-19 to take a p
MarketWatchOct 15

FDA to hold advisory committee for Merck's experimental COVID-19 pill

Shares of Merck & Co. Inc. MRK, -0.79% were down 0.1% in premarket trading on Friday, the day after the Food and Drug Administration said it plans to convene an
BloombergOct 14

Sydney to End Quarantine, Moderna Gets Booster Nod: Virus Update

(Bloomberg) -- Australia’s most populous state will end the requirement for vaccinated travelers to quarantine from Nov. 1. Most Read from Bloomberg Booster s
MarketWatchOct 14

The success of Merck’s antiviral—and other COVID-19 pills in development—may depend on how quickly people start taking them

In the not-too-distant future, you may be able to walk into a doctor’s office, get tested for SARS-CoV-2, and walk out with pills or a prescription if you end u
ReutersOct 13

Holocene Advisors says Merck's offer undervalues Acceleron

The Merck logo is seen on a sign at the Merck & Co campus in Rahway, New Jersey (Reuters) - Investment management firm Holocene Advisors said it will not tende
WiredOct 13

William Shatner Answers the Web's Most Searched Questions

MarketWatch The buzz surrounding the potential for the antiviral drug from Merck & Co. (MRK) and Ridgeback Biotherapeutics is hot enough that already there’s p
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure